D. M. O’Connor

Adeno‐associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling

F. Epstein, J. Hossack, R. Beyers, 2012, The journal of gene medicine.

Cardiac-Selective Expression of Extracellular Superoxide Dismutase After Systemic Injection of Adeno-Associated Virus 9 Protects the Heart Against Post–Myocardial Infarction Left Ventricular Remodeling

Marc E. Seaman, R. Beyers, Yaqin Xu, 2013, Circulation. Cardiovascular imaging.

A novel cardiac muscle-derived biomaterial reduces dyskinesia and postinfarct left ventricular remodeling in a mouse model of myocardial infarction

F. Epstein, J. Hossack, Yaqin Xu, 2015, Physiological reports.

Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction

Yaqin Xu, B. A. French, N. Thomas, 2016, Gene Therapy.

Systemic Delivery of shRNA by AAV9 Provides Highly Efficient Knockdown of Ubiquitously Expressed GFP in Mouse Heart, but Not Liver

B. A. French, B. Piras, D. M. O’Connor, 2013, PloS one.

Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote‐Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction

J. Hossack, R. Beyers, B. A. French, 2016, Journal of the American Heart Association.